The industry’s perplexity revolves around measuring these emissions accurately, especially across a diffuse supply chain. Justin Chiarodo of Blank Rome LLP highlights the significant challenge of establishing fair and objective standards. Republican lawmakers express qualms about a proposed third-party organization, the Science Based Targets Initiative, adding another layer of uncertainty to the emission reduction targets.
Gov’t Contracting Policies To Watch In 2024 : Federal Buying Power
The White House unveils its trump card — the “Better Contracting” initiative — signaling a strategic shift in how the federal government flexes its colossal buying power. Pledging to spend over $600 billion annually, the government aims to optimize its purchases through a four-pronged approach. From leveraging data and negotiating common software licenses to avoiding waste and ensuring value in sole-source contracts, the initiative is a labyrinth of tactics aimed at obtaining better terms and prices.
Government Flex on Patent Rights Adds More Uncertainty for Contracting Landscape
The December framework from the White House introduces a game-changer in the form of “march-in rights” for taxpayer-funded inventions, including prescription drugs. While initially focused on highly priced drugs, the implications extend to all innovations funded by federal money. Amy Hoang from Seyfarth Shaw LLP notes the potential ripple effects, as the specter of exercising these rights adds another layer of complexity to the already intricate world of government contracting
